Reuters (7/20, Rapaport) reports, “When babies are extremely premature, parents are about 10 times more likely to become depressed than mothers and fathers of full-term, healthy infants,” research suggests. Included in the study were “113 mothers and 101 fathers of preemies, as well as 117 mothers and 151 fathers of healthy, full-term infants.” The findings were published online July 18 in JAMA Pediatrics.

Related Links:

— “Parents of preemies often depressed after birth,” Lisa Rapaport, Reuters, July 20, 2016.

Fox News (7/19, Carstensen) reports that “a new randomized, placebo-controlled clinical trial suggests” hormone “therapy does not impact mental skills like verbal memory…regardless of when an individual begins taking estradiol after menopause.”

Related Links:

— “Hormone therapy has no effect on verbal memory after menopause, study suggests,” Melinda Carstensen, Fox News, July 19, 2016.

HealthDay (7/18, Dotinga) reports researchers found that certain types of hits to high school football players’ heads are especially damaging to players, according to a new study published in Pediatrics. The researchers reviewed data collected from devices inside football helmets and found that hits to the head that were preceded by running a long distance as well as hits caused by other players were especially damaging, according to University of Georgia assistant professor Julianne Schmidt, the study’s author.

Related Links:

— “Concussion Study Shows Player-to-Player Hits Most Damaging,” Randy Dotinga, HealthDay, July 18, 2016.

The Washington Post (7/18, Hurley) reports that the Food and Drug Administration has concluded “that for carefully selected patients with profound depression, the benefits of electroconvulsive therapy…outweigh the risks of possible memory loss caused by its use.”

The FDA “is proposing to downgrade” ECT from Class III to Class II “for those whose depression has not responded to other treatments or is so severe that they need the kind of rapid response that only ECT can provide.”

However, the FDA “said that too few randomized trials have been published to justify a Class II designation” for other medical conditions like catatonia.

Related Links:

— “FDA: Electroshock has risks but is useful to combat severe depression,” Dan Hurley, Washington Post, July 19, 2016.

In a patient advice column in US News & World Report (7/15), psychiatrist and American Psychiatric Association (APA) past president Jeffrey Lieberman, MD, wrote that over the past five decades, “progress in science and technology…has dramatically changed the scientific basis and therapeutic capability of psychiatry.”

These days, “the greatest hindrance to effective care is not a gap in medical knowledge or a shortcoming in effective treatments, but the enduring social stigma of mental illness and the understandable – but no longer warranted – lack of confidence in the competence of psychiatrists.” Patients needing a referral to a psychiatrist should start with their own primary care physician, but district branches of the APA can also help patients “find a well-trained a competent psychiatrist.”

Related Links:

— “When Should You See a Shrink?,” Jeffrey Lieberman, US News & World Report, July 15, 2016.